Birateron in the Therapy of Metastic Castratin Resistant Cardinal Prostate Before Immediately of Chemotherapy
dc.contributor.author | Richter Igor | cs |
dc.contributor.author | Dvořák Josef | cs |
dc.contributor.author | Bartoš Jiří | cs |
dc.contributor.author | Hejzlarová Věra | cs |
dc.contributor.author | Barsová Lucie | cs |
dc.contributor.author | Forster J. | cs |
dc.date.accessioned | 2018-09-25T12:19:37Z | |
dc.date.available | 2018-09-25T12:19:37Z | |
dc.date.issued | 2017-01-01 | cs |
dc.format.extent | 0 | cs |
dc.identifier.uri | https://dspace.tul.cz/handle/15240/31984 | |
dc.language.iso | cze | cs |
dc.relation.ispartofseries | 0 | cs |
dc.subject | abiraterone acetate | cs |
dc.subject | metastatic castrant-resistant prostate cancer | cs |
dc.title | Birateron in the Therapy of Metastic Castratin Resistant Cardinal Prostate Before Immediately of Chemotherapy | en |
dc.title | Abirateron V Léčbě Metastatického Kastračně Rezistentního Karcinomu Prostaty Před Podáním Chemoterapie | cs |
local.identifier.publikace | 5455 |